Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
AssigneeNew England Medical Center
InventorMark J. Rivard
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Medical Center
InventorMark J. Rivard
Estimating the term…
The present invention discloses a methodology for the characterization and determination of mixed-field dosimetry for 252Cf Applicator Tube (AT)-type medical sources, utilizing ionization chambers, GM counters, and Monte Carlo methods. Unlike the previous methodologies, the present invention discloses a specification of dose to muscle, rather than dose to water, for clinical dosimetry of 252Cf medical sources. A dosimetry protocol, similar to that utilized for ICRU-45, with parameters determined specifically for 252Cf brachytherapy is disclosed. Neutron isodose distributions and data necessary for clinical implementation of 252Cf AT sources are also disclosed herein. Additionally, novel methods for the encapsulation, storage, and delivery/implantation of 252Cf radionuclide sources are disclosed.
A method for the use of a neutron-emitting brachytherapy source, said method comprising:
A method for the use of a neutron-emitting brachytherapy source, the method comprising administering a radiation dose to an individual in need of the dose via neutron brachytherapy, the dose being determined from a water-based teletherapy dosimetry formalism modified to provide dosimetry based upon material characteristics of at least one of tissue and tissue-simulating media instead of water.
Dependencies are inferred from the claim text.